The plenary session presented information on the evolving structure of the EORTC as well as the clinical research landscape and new forms of clinical research activities covering the full span from early clinical trials to survivorship. Exchanging views with other stakeholders and discussing the role of academia will be major highlights.
EGAM 2015 also marked a special celebration in honor of Françoise Meunier, Director General and her many significant contributions to the EORTC over the past two and a half decades.
General introduction, Roger Stupp
The patients perspectives and survival issues, Isabelle Lebrocquy
Cancer Management and Transatlantic cooperation, Richard Schilsky
The EORTC Charitable Trust, Diego du Monceau
EORTC future perspectives, Roger Stupp